Table 6. Univariate analysis of survival in endometrial cancer (EAC).

Variable	Median survival time Month (±SE)	95% CI (Month)	P
Age (years)			0.997
<60	52.03 (2.66)	46.82–57.24
≥60	49.40 (3.89)	41.79–57.02
Tumor size			<0.001
≥5	67.61 (2.11)	63.47–71.75
<5	44.61 (2.56)	39.60–49.62
Grade			<0.001
I–II	63.58 (3.78)	56.17–70.99
III	46.08 (2.42)	41.35–50.82
Tumor status			0.898
T1–T2	53.84 (2.69)	48.58–59.10
T3–T4	48.10 (3.51)	41.22–54.99
Node status			0.005
Negative	60.42 (2.92)	54.70–66.15
Positive	45.70 (2.80)	40.22–51.19
Distant metastasis			0.013
No	55.17 (3.7)	47.92–62.42
Yes	48.15 (2.60)	43.06–53.24
uc.189			<0.001
High expression	43.52 (2.26)	39.10–47.94
Low/unchanged	72.99 (1.84)	69.39–76.59
Stage			0.374
I–II	52.96 (3.88)	45.36–60.56
III–IV	49.97 (2.62)	44.85–55.10